Drugs / MMRII
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00871117 Background | Mar 2009 → Jan 2010 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M-M-RII | “receive either Kinrix, Varivax and M-M-RII on day 0 (Group 1)” NCT00871117 ↗ |
| Modality | Vaccine | “(measles mumps rubella) MMR vaccines” NCT00871117 ↗ |
| Route | Subcutaneous | “One dose as subcutaneous injection at visit 1” NCT00871117 ↗ |